Retinal dysfunction in APOE4 knock-in mouse model of Alzheimer's disease
- PMID: 39749840
- PMCID: PMC11848189
- DOI: 10.1002/alz.14433
Retinal dysfunction in APOE4 knock-in mouse model of Alzheimer's disease
Abstract
Introduction: Late-onset Alzheimer's Disease (LOAD) is the predominant form of Alzheimer's disease (AD), and apolipoprotein E (APOE) ε4 is a strong genetic risk factor for LOAD. As an integral part of the central nervous system, the retina displays a variety of abnormalities in LOAD. Our study is focused on age-dependent retinal impairments in humanized APOE4-knock-in (KI) and APOE3-KI mice developed by the Model Organism Development and Evaluation for Late-Onset Alzheimer's Disease (MODEL-AD) consortium.
Methods: All the experiments were performed on 52- to 57-week-old mice. The retina was assessed by optical coherence tomography, fundoscopy, fluorescein angiography, electroretinography, optomotor response, gliosis, and neuroinflammation. mRNA sequencing was performed to find molecular pathways.
Results: APOE4-KI mice showed impaired retinal structure, vasculature, function, vision, increased gliosis and neuroinflammation, and downregulation of synaptogenesis.
Discussion: The APOE ε4 allele is associated with increased susceptibility to retinal degeneration compared to the APOE ε3 allele.
Highlights: Apolipoprotein E (APOE)4 mice exhibit structural and functional deficits of the retina. The retinal defects in APOE4 mice are attributed to increased neuroinflammation. APOE4 mice show a unique retinal transcriptome, yet with key brain similarities. The retina offers a non-invasive biomarker for the detection and monitoring of Alzheimer's disease.
Keywords: APOE; Late‐Onset Alzheimer's Disease; biomarker; retina; retinal dysfunction.
© 2024 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
A.B. is an ad hoc District Support Pharmacist at CVS Health/Aetna. The contents of this study do not reflect those of CVS Health/Aetna. Q.L., G.H., N.M., T.W.C., A.L.O., B.T.L., and S.A. do not have any conflicts to declare. Author disclosures are available in the Supporting information.
Figures






Similar articles
-
ApoE4 induces synaptic and ERG impairments in the retina of young targeted replacement apoE4 mice.PLoS One. 2013 May 31;8(5):e64949. doi: 10.1371/journal.pone.0064949. Print 2013. PLoS One. 2013. PMID: 23741431 Free PMC article.
-
VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina.Curr Alzheimer Res. 2015;12(4):323-34. doi: 10.2174/1567205012666150325182504. Curr Alzheimer Res. 2015. PMID: 25817253
-
The Effects of Gene-Environment Interactions Between Cadmium Exposure and Apolipoprotein E4 on Memory in a Mouse Model of Alzheimer's Disease.Toxicol Sci. 2020 Jan 1;173(1):189-201. doi: 10.1093/toxsci/kfz218. Toxicol Sci. 2020. PMID: 31626305 Free PMC article.
-
ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.Neurobiol Aging. 2022 Jul;115:20-28. doi: 10.1016/j.neurobiolaging.2022.03.011. Epub 2022 Mar 22. Neurobiol Aging. 2022. PMID: 35453035 Free PMC article. Review.
-
APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease.Neurobiol Dis. 2020 Jun;139:104834. doi: 10.1016/j.nbd.2020.104834. Epub 2020 Mar 12. Neurobiol Dis. 2020. PMID: 32173556 Free PMC article. Review.
Cited by
-
Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer's Disease.Int J Mol Sci. 2025 Jun 10;26(12):5541. doi: 10.3390/ijms26125541. Int J Mol Sci. 2025. PMID: 40565005 Free PMC article. Review.
-
Long-term Dietary Fat Intervention Affects Retinal Health in APOE Mice.bioRxiv [Preprint]. 2025 Aug 1:2025.07.30.667671. doi: 10.1101/2025.07.30.667671. bioRxiv. 2025. PMID: 40766498 Free PMC article. Preprint.
-
Retinal manifestations and their diagnostic significance in Alzheimer's disease.J Alzheimers Dis Rep. 2025 Aug 10;9:25424823251361937. doi: 10.1177/25424823251361937. eCollection 2025 Jan-Dec. J Alzheimers Dis Rep. 2025. PMID: 40799319 Free PMC article. Review.
References
-
- Bales KR. The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update. Expert Opin Drug Discov. 2012;7(4):281‐297. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous